|Bid||0.00 x 800|
|Ask||0.00 x 900|
|Day's Range||176.75 - 181.00|
|52 Week Range||126.94 - 231.00|
|Beta (5Y Monthly)||1.43|
|PE Ratio (TTM)||30.81|
|Earnings Date||Oct 24, 2022 - Oct 28, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||147.00|
Subscribe to Yahoo Finance Plus to view Fair Value for MEDP
While Medpace Holdings, Inc. ( NASDAQ:MEDP ) might not be the most widely known stock at the moment, it led the...
Factoring the pandemic and competitive pressure as well as the evolving economic environment, including inflation and the threat of recession, Tandem Diabetes (TNDM) cuts its full-year guidance.
Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.